These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 31346700)
1. Metformin and ovarian cancer survival: is there a rational warrant for belief? Mormile R Arch Gynecol Obstet; 2019 Oct; 300(4):797-798. PubMed ID: 31346700 [TBL] [Abstract][Full Text] [Related]
2. Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study. Wang SB; Lei KJ; Liu JP; Jia YM Medicine (Baltimore); 2017 Jul; 96(29):e7605. PubMed ID: 28723808 [TBL] [Abstract][Full Text] [Related]
4. Metformin Antagonizes Ovarian Cancer Cells Malignancy Through MSLN Mediated IL-6/STAT3 Signaling. Yang X; Huang M; Zhang Q; Chen J; Li J; Han Q; Zhang L; Li J; Liu S; Ma Y; Li L; Yang L; Zou S; Han B Cell Transplant; 2021; 30():9636897211027819. PubMed ID: 34238029 [TBL] [Abstract][Full Text] [Related]
5. [Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes]. Bershteĭn LM; Turkevich EA; Boiarkina MP Vopr Onkol; 2012; 58(2):194-8. PubMed ID: 22774523 [TBL] [Abstract][Full Text] [Related]
6. Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer. Henderson D; Frieson D; Zuber J; Solomon SS Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830 [TBL] [Abstract][Full Text] [Related]
7. Repurposed Drugs Trials for Ovarian Cancer. DiFeo A Cancer J; 2019; 25(2):149-152. PubMed ID: 30896539 [No Abstract] [Full Text] [Related]
9. Association between pancreatic cancer and metformin use in patients with type 2 diabetes. Lai SW; Tsai CH; Lin CL; Liao KF Postgrad Med J; 2019 May; 95(1123):291. PubMed ID: 30975725 [No Abstract] [Full Text] [Related]
12. Metformin for lung cancer prevention and improved survival: a novel approach. Roos JF; Qudsi M; Samara A; Rahim MM; Al-Bayedh SA; Ahmed H Eur J Cancer Prev; 2019 Jul; 28(4):311-315. PubMed ID: 29481337 [TBL] [Abstract][Full Text] [Related]
14. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy. Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671 [TBL] [Abstract][Full Text] [Related]
15. Metformin: fifty-two not out. Campbell IW J Indian Med Assoc; 2009 Nov; 107(11):779-84. PubMed ID: 20469782 [No Abstract] [Full Text] [Related]
16. [Metformin role in the treatment of type 2 diabetes in 2008]. Spada A; Philippe J Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062 [TBL] [Abstract][Full Text] [Related]
17. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus. Tseng CH Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555 [TBL] [Abstract][Full Text] [Related]
18. Metformin in cancer. Mallik R; Chowdhury TA Diabetes Res Clin Pract; 2018 Sep; 143():409-419. PubMed ID: 29807101 [TBL] [Abstract][Full Text] [Related]
19. Metformin for Prevention and Treatment of Colon Cancer: A Reappraisal of Experimental and Clinical Data. Anisimov VN Curr Drug Targets; 2016; 17(4):439-46. PubMed ID: 25738299 [TBL] [Abstract][Full Text] [Related]
20. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer. Guppy A; Jamal-Hanjani M; Pickering L Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]